PIGS
Basic information
Region (hg38): 17:28553383-28571794
Links
Phenotypes
GenCC
Source:
- glycosylphosphatidylinositol biosynthesis defect 18 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 18 (Moderate), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 18 (Strong), mode of inheritance: AR
- glycosylphosphatidylinositol biosynthesis defect 18 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Developmental and epileptic encephalopathy 95 | AR | Neurologic | Among other manifestations, individuals may have difficult-to-control seizures, and management with oral pyridoxine has been described as beneficial | Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic | 30269814; 33410539 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (67 variants)
- not_provided (34 variants)
- Glycosylphosphatidylinositol_biosynthesis_defect_18 (17 variants)
- PIGS-related_disorder (15 variants)
- not_specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGS gene is commonly pathogenic or not. These statistics are base on transcript: NM_000033198.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 15 | 15 | ||||
| missense | 74 | 10 | 93 | |||
| nonsense | 4 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 7 | 5 | 76 | 25 | 3 |
Highest pathogenic variant AF is 0.00002395308
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PIGS | protein_coding | protein_coding | ENST00000308360 | 12 | 18490 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000181 | 0.994 | 125693 | 0 | 55 | 125748 | 0.000219 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.780 | 285 | 325 | 0.878 | 0.0000178 | 3564 |
| Missense in Polyphen | 65 | 91.769 | 0.7083 | 1036 | ||
| Synonymous | 0.172 | 133 | 136 | 0.981 | 0.00000762 | 1172 |
| Loss of Function | 2.45 | 12 | 25.3 | 0.475 | 0.00000116 | 303 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000397 | 0.000391 |
| Ashkenazi Jewish | 0.000497 | 0.000496 |
| East Asian | 0.000275 | 0.000272 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.000283 | 0.000281 |
| Middle Eastern | 0.000275 | 0.000272 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the GPI transamidase complex. Essential for transfer of GPI to proteins, particularly for formation of carbonyl intermediates. {ECO:0000269|PubMed:11483512}.;
- Pathway
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.708
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.57
Haploinsufficiency Scores
- pHI
- 0.205
- hipred
- N
- hipred_score
- 0.426
- ghis
- 0.533
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.421
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pigs
- Phenotype
Gene ontology
- Biological process
- attachment of GPI anchor to protein
- Cellular component
- endoplasmic reticulum membrane;membrane;GPI-anchor transamidase complex
- Molecular function
- GPI-anchor transamidase activity;protein binding